Literature DB >> 7795172

Identification of differentially glycosylated forms of the soluble p75 tumor necrosis factor (TNF) receptor in human urine.

A Corti1, F D'Ambrosio, M Marino, S Merli, G Cassani.   

Abstract

Human urine is known to contain a 30 kDa soluble form of the p75-TNF receptor (sTNF-R2). In this work we have purified sTNF-R2 from the urine of normal subjects and further characterized its structure and activity. sTNF-R2 was resolved by reducing SDS-PAGE in a major band of 30 kDa, similar in size to the previously described urinary sTNFR2, and in a minor band of 45 kDa. "Western" blotting analysis with anti-TNF-R1 and anti-TNF-R2 antibodies showed that both bands were immunologically related to the membrane TNF-R2. Glycosylation studies indicated that the 30 kDa is N-glycosylated while the 45 kDa form is N- and O-glycosylated, and suggested that both forms contain terminally linked sialic acid that is differentially recognized by lectins. These results indicate that human urine contains, besides the 30 kDa form, a new form of 45 kDa characterized by different glycosylation type and degree.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7795172

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  3 in total

1.  Colocalization of endogenous TNF with a functional intracellular splice form of human TNF receptor type 2.

Authors:  Christoph Scherübl; Wulf Schneider-Brachert; Stephan Schütze; Thomas Hehlgans; Daniela N Männel
Journal:  J Inflamm (Lond)       Date:  2005-07-04       Impact factor: 4.981

2.  TNF-α and microalbuminuria in patients with type 2 diabetes mellitus.

Authors:  I-Th Lampropoulou; M Stangou; A Papagianni; T Didangelos; F Iliadis; G Efstratiadis
Journal:  J Diabetes Res       Date:  2014-12-22       Impact factor: 4.011

3.  The Effect of Human Recombinant Tumor Necrosis Factor Receptor-2 on Reducing Inflammatory of Collagen -Induced Arthritis in Balb/c Mice.

Authors:  Shahla Korani; Bahram Kazemi; Adel Haghighi; Amin Reza Nikpoor; Mojgan Bandehpour
Journal:  Iran J Biotechnol       Date:  2019-01-11       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.